Good response to cyclosporine therapy in patients with myelodysplastic syndromes having the HLA-DRB1*1501 allele.
Okamoto
T
T
Okada
M
M
Yamada
S
S
Takatsuka
H
H
Wada
H
H
Tamura
A
A
Fujimora
Y
Y
Takemoto
Y
Y
Kakishita
E
E
D000328:Adult; D000368:Aged; D000483:Alleles; D016572:Cyclosporine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D005838:Genotype; D006684:HLA-DR Antigens / Q000187:drug effects / Q000235:genetics*; D059811:HLA-DRB1 Chains; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009190:Myelodysplastic Syndromes / Q000188:drug therapy* / Q000235:genetics* / Q000276:immunology; D016896:Treatment Outcome
D006684:HLA-DR Antigens; D059811:HLA-DRB1 Chains; D007166:Immunosuppressive Agents; D016572:Cyclosporine